Consumer Updates > The FDA Encourages New Treatments for Sickle Cell Disease

Consumer Updates > The FDA Encourages New Treatments for Sickle Cell Disease

	The FDA Encourages New Treatments for Sickle Cell Disease
		Sickle cell disease is the most common inherited blood disorder in the United States. New treatments are needed to prevent and treat its serious complications. That’s why the U.S. Food and Drug Administration is working with patients and stakeholders to help. Read the article, and see the related video, to learn how the FDA is encouraging innovation.